GaldermaDeliversRecord2025ResultsWithNetSalesof5.207BillionUSD,up17.7%atConstantCurrency1,andCoreEBITDA2of1.211billionUSD,Growing18.9%atConstantCurrency
===2026/3/5 16:11:22===
(93)
(59)
EBITDA
938
1,152
% margin
21.3%
22.1%
Depreciation
(64)
(77)
Amortization
(229)
(246)
Operating profit
645
829
Net financial expenses (incl. VCB revaluation in FY 2024)
(328)
=*=*=*=*=*=
当前为第38/55页
下一页-上一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页
